|1.||Abe, Shigeru: 3 articles (01/2015 - 01/2012)|
|2.||Hayama, Kazumi: 3 articles (01/2015 - 01/2012)|
|3.||Takahashi, Miki: 3 articles (01/2015 - 01/2012)|
|4.||Ninomiya, Kentaro: 2 articles (01/2013 - 01/2012)|
|5.||Żarnowski, Tomasz: 1 article (03/2015)|
|6.||Gasior, Maciej: 1 article (03/2015)|
|7.||Nieoczym, Dorota: 1 article (03/2015)|
|8.||Wlaź, Piotr: 1 article (03/2015)|
|9.||Czuczwar, Stanisław J: 1 article (03/2015)|
|10.||Socała, Katarzyna: 1 article (03/2015)|
|1.||Oral Candidiasis (Thrush)
01/01/2013 - "Based on these results, the combined agent of terpinen-4-ol and capric acid was discussed as a possible candidate for oral candidiasis therapy."
01/01/2013 - "[Effects of inhibitory activity on mycelial growth of Candida albicans and therapy for murine oral candidiasis by the combined use of terpinen-4-ol and a middle-chain fatty acid, capric acid]."
01/01/2012 - "[Inhibition of Candida mycelia growth by a medium chain fatty acids, capric acid in vitro and its therapeutic efficacy in murine oral candidiasis]."
01/01/2015 - "In a preceding paper, we showed that aroma candy containing oligonol, capric acid, and cinnamon (cassia) powder had potent inhibitory activity against mycelial growth of Candida albicans in vitro and protective activity against murine oral candidiasis. "
01/01/2013 - "The combined effect of terpinen-4-ol, the main component of tea tree oil, and capric acid against mycelial growth of Candida albicans and murine oral candidiasis was evaluated in vitro and in vivo. "
03/03/2015 - "Acute anticonvulsant effects of capric acid in seizure tests in mice."
12/01/1986 - "Octanoic and decanoic acid, the major constituents of the Medium Chain Triglyceride (MCT) Emulsion diet, have been detected in appreciable quantities in the peripheral blood of children with intractable seizures treated with the MCT diet. "
12/01/1986 - "No correlation between octanoic and decanoic acid concentrations and control of seizures was established, but further studies with octanoic and decanoic acid using animal models are necessary to assess the role of these acids and of control of seizures."
03/01/2015 - "Additionally, the potential of sodium caprate was confirmed by a tumor-bearing small animal model. "
12/01/1993 - "n-Decanoic acid did not function as a tumor promoter. "
04/01/2013 - "Conjugation of decanoic acid (C10) to peptides resulted in similar or higher IC(50) values compared to R10 conjugates but C10 conjugates did not exhibit any cancer selectivity. "
04/01/2013 - "Peptide conjugated with a terminally hydroxylated decanoic acid (ω-hydroxydecanoic acid) exhibited 3.3 and 6.3 fold higher IC(50) values compared to R10 conjugated peptide indicating a role for the position of the hydroxyl moiety in enhancement of anti-cancer activity. "
12/01/1993 - "Because fatty acids are known to participate in signal transduction pathways, and since cellular lipases could cleave the fatty acid side chains present in DIC10, we have examined the tumor promoting activity of n-decanoic acid to verify the specificity of promotional activity of DIC10. "
|4.||Wolman Disease (Wolman's Disease)
06/15/1988 - "Skin fibroblasts, derived from normal individuals or patients with Wolman's disease (an autosomal recessive disorder due to acid lysosomal lipase deficiency) were incubated with the fluorescent fatty acid, pyrene-decanoic acid (P10). "
03/13/1987 - "Cholesteryl esters with various chain lengths of fatty acid, radioactive (C2-C18:1) and fluorescent (pyrene butanoic and decanoic acid, P4 and P10, respectively) were synthesized and their hydrolysis was investigated in lymphoid cell lines from normal subjects and from Wolman's disease patients. "
10/01/1999 - "Myocardial tomographies with thallium and I-123-labeled-beta-methyl-p-iodophenyl penta-decanoic acid (BMIPP) were performed in 27 acute myocardial infarct patients treated medically: 15 patients had preexisting angina before infarction (group A) and 12 did not (group B). "
09/01/1998 - "Tomographic imagings with thallium and beta-methyl-p-iodophenyl penta-decanoic acid (BMIPP) were performed in 32 patients with first acute myocardial infarction who received primary coronary angioplasty: 20 patients with preexisting angina before infarction (Group A) and 12 without (Group B). "
|1.||Fatty Acids (Saturated Fatty Acids)
|6.||Palmitic Acid (Hexadecanoic Acid)
|8.||Fluorescent Dyes (Fluorescent Probes)
|9.||caprylic acid (octanoate)
|10.||Tea Tree Oil
|2.||Angioplasty (Angioplasty, Transluminal)
|3.||Respiratory Therapy (Therapy, Respiratory)